NCT05722782View on ClinicalTrials.gov

Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics

PHASE2RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Renal Colic
Interventions
DRUG

Piroxicam

Patients allocated to this arm received , as a second line treatment of renal colics , a five days treatment with 20 mg piroxicam per day and were contacted at the seventh day by telephone call to investigate the efficacy and the side effects of the treatment

DRUG

Acetaminophen

Patients allocated to this arm received , as a second line treatment of renal colics , a five days treatment with 1000 mg Acetaminophen per day and were contacted at the seventh day by telephone call to investigate the efficacy and the side effects of the treatment

DRUG

Placebo

Patients allocated to this arm received , as a second line treatment of renal colics , a five days treatment with placebo per day and were contacted at the seventh day by telephone call to investigate the efficacy and the side effects of the treatment

Trial Locations (1)

5000

RECRUITING

Fattouma Bourguiba University Hospital, Monastir

All Listed Sponsors
lead

University of Monastir

OTHER